Madison-based HealthMyne, announced the appointment of Mimi Huizinga, MD, MPH, FACP, to its board of directors. Dr. Huizinga is the vice president and head of U.S. Oncology Medical for Novartis.
Huizinga has served as vice president, strategic data and digital, U.S. oncology, with Novartis and as chief health information officer and vice president, chief clinical officer, population health, with Premier Inc. HealthMyne is an applied radiomics company working to extract novel data and biomarkers from medical images for cancer treatment.
